Kawsar Talaat, MD
Infectious Disease · Baltimore, MDNPI 1588858740
Payments from drug & device makers
Across 351 payments — averaging $11,903 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$3.5M
- Sanofi Pasteur Inc.$369K
- Valneva Austria GmbH$228K
- Merck$32K
- Sanofi US Services Inc.$27K
- Modernatx, Inc.$14K
- plus $45 from 1 others
Across 10 payments — averaging $1510.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$15K
What the payments were for
- Consulting fees$45,673100%
- Food & beverage$450%
- Gifts$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 203 | $3,508,339 |
| Sanofi Pasteur Inc. | 62 | $369,393 |
| Valneva Austria GmbH | 2 | $227,737 |
| Merck | 45 | $31,988 |
| Sanofi US Services Inc. | 32 | $26,869 |
| Modernatx, Inc. | 6 | $13,685 |
| Seqirus USA Inc | 1 | $45 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GARDASIL 9$8,145
- V160$5,944
- ENFLONSIA$698
How this compares
$4,178,055 in reported general payments places this provider in the 95th percentile of 289 infectious disease providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Baltimore
- Mohamed Al IbrahimBaltimore$4.9M
- Joel ChuaBaltimore$2.4M
- Elana RosenthalBaltimore$1.6M
- Cynthia SearsBaltimore$1.4M
- Robin AveryBaltimore$1.3M
- Peter KadlecikBaltimore$1.2M
- Kathleen NeuzilBaltimore$1.1M
- Wilbur ChenBaltimore$971K
- Oluwaseun FaladeBaltimore$956K
- Mark SulkowskiBaltimore$909K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.